This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Jul 1;12(13):3871-4.

doi: 10.1158/1078-0432.CCR-06-1017.

Challenges of evaluating the cardiac effects of anticancer agents

Susan E Bates, Douglas R Rosing, Tito Fojo, Richard L Piekarz

PMID: 16818679
DOI: 10.1158/1078-0432.CCR-06-1017

Review

Challenges of evaluating the cardiac effects of anticancer agents

Susan E Bates et al. Clin Cancer Res. 2006.

. 2006 Jul 1;12(13):3871-4.

doi: 10.1158/1078-0432.CCR-06-1017.

Authors

Susan E Bates, Douglas R Rosing, Tito Fojo, Richard L Piekarz

PMID: 16818679
DOI: 10.1158/1078-0432.CCR-06-1017

No abstract available

PubMed Disclaimer

Comment on

Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors.
Shah MH, Binkley P, Chan K, Xiao J, Arbogast D, Collamore M, Farra Y, Young D, Grever M. Shah MH, et al. Clin Cancer Res. 2006 Jul 1;12(13):3997-4003. doi: 10.1158/1078-0432.CCR-05-2689. Clin Cancer Res. 2006. PMID: 16818698 Clinical Trial.

Similar articles

[Cardiotoxicity of antineoplastic drugs].
Drzewoski J, Kasznicki J. Drzewoski J, et al. Acta Haematol Pol. 1992;23(2):79-86. Acta Haematol Pol. 1992. PMID: 1488864 Review. Polish.
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
Ewer MS, Lippman SM. Ewer MS, et al. J Clin Oncol. 2005 May 1;23(13):2900-2. doi: 10.1200/JCO.2005.05.827. J Clin Oncol. 2005. PMID: 15860848 No abstract available.
Patients undergoing cancer treatments need monitoring to prevent heart injuries.
[No authors listed] [No authors listed] Health News. 2004 Nov;10(11):9. Health News. 2004. PMID: 15655855 No abstract available.
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
Jones RL, Ewer MS. Jones RL, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1249-69. doi: 10.1586/14737140.6.9.1249. Expert Rev Anticancer Ther. 2006. PMID: 17020459 Review.
"First, do no harm": chemotherapy or healthy heart?
Dimos AK, Stougiannos PN, Trikas AG. Dimos AK, et al. Hellenic J Cardiol. 2012 Mar;53(2):127-36. Hellenic J Cardiol. 2012. PMID: 22484778 Review. No abstract available.

See all similar articles

Cited by

A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors.
Fukutomi A, Hatake K, Matsui K, Sakajiri S, Hirashima T, Tanii H, Kobayashi K, Yamamoto N. Fukutomi A, et al. Invest New Drugs. 2012 Jun;30(3):1096-106. doi: 10.1007/s10637-011-9666-9. Epub 2011 Apr 12. Invest New Drugs. 2012. PMID: 21484248 Clinical Trial.
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.
Tharkar-Promod S, Johnson DP, Bennett SE, Dennis EM, Banowsky BG, Jones SS, Shearstone JR, Quayle SN, Min C, Jarpe M, Mosbruger T, Pomicter AD, Miles RR, Chen WY, Bhalla KN, Zweidler-McKay PA, Shrieve DC, Deininger MW, Chandrasekharan MB, Bhaskara S. Tharkar-Promod S, et al. Leukemia. 2018 Jan;32(1):49-60. doi: 10.1038/leu.2017.174. Epub 2017 Jun 5. Leukemia. 2018. PMID: 28579617 Free PMC article.
Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy.
Brell JM. Brell JM. Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):164-72. doi: 10.1016/j.pcad.2010.05.005. Prog Cardiovasc Dis. 2010. PMID: 20728704 Free PMC article. Review.
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE. Piekarz RL, et al. Blood. 2011 Jun 2;117(22):5827-34. doi: 10.1182/blood-2010-10-312603. Epub 2011 Feb 25. Blood. 2011. PMID: 21355097 Free PMC article. Clinical Trial.
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.
Locatelli M, Criscitiello C, Esposito A, Minchella I, Goldhirsch A, Cipolla C, Curigliano G. Locatelli M, et al. Target Oncol. 2015 Mar;10(1):27-43. doi: 10.1007/s11523-014-0325-x. Epub 2014 Jun 27. Target Oncol. 2015. PMID: 24970120 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information